Advanced Cancer Therapeutics competitorsClear all

Advanced Cancer Therapeutics's top competitors include Alpha Tau Medical, Gossamer Bio, Forty Seven and Amal Therapeutics.
Advanced Cancer Therapeutics
Advanced Cancer Therapeutics
Advanced Cancer Therapeutics (ACT) is a biotechnology company focused on the discovery and early development of novel cancer therapeutics.
Alpha Tau Medical
Alpha Tau Medical
Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.
Gossamer Bio
Gossamer Bio
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
Forty Seven
Forty Seven
Forty Seven is an immuno-oncology company, which develops therapies that target cancer immune evasion pathways.
Amal Therapeutics
Amal Therapeutics
Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology.
Founding Date
Founding Date
2007
Founding Date
2016
Founding Date
2015
Founding Date
2014
Founding Date
N/A
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Louisville, US HQ
Locations
Tel Aviv-Yafo, IL HQ
Boston, US
Locations
San Diego, US HQ
Dublin 2, IE
Locations
Menlo Park, US HQ
Mountain View, US
Sacramento, US
Locations
Genève, CH HQ
Employees
Employees
1
Employees
452% increase
Employees
11820% increase
Employees
62
Employees
19
Twitter followers
Twitter followers
N/A
Twitter followers
612
Twitter followers
181
Twitter followers
N/A
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
3.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
375692
Alexa Website Rank
210586
Alexa Website Rank
367101
Alexa Website Rank
336604
Alexa Website Rank
481809

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($180.3m) (FY, 2019)
Net income
($87.6m) (FY, 2019)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 10m (about 10 years ago)
Latest funding round
$ 26m (4 months ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 55m
Total funding raised
$ 480m
Total funding raised
$ 156m
Total funding raised
$ 45.5m
For sources of this data, please see the company profile

View company profiles

Alpha Tau Medical
HQ
Tel Aviv-Yafo, IL
Employees
45↑ 2% increase

Alpha Tau Medical focuses on research, development, and commercialization of diffusing alpha-emitters radiation therapy (DaRT) for the treatment of solid cancer tumors.

View company
Gossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase

Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.

View company
Forty Seven
HQ
Menlo Park, US
Employees
62

Forty Seven is an immuno-oncology company, which develops therapies that target cancer immune evasion pathways.

View company
Amal Therapeutics
HQ
Genève, CH

Amal Therapeutics is a biotech company, which engages in the research and development of therapeutic vaccines in oncology.

View company